Control of microbial contamination during surgical harvest of pig renal xenografts

Xenotransplantation

Volumn 11, Issue 1, 2004, Pages 91-96

  Tucker, Alexander W ^a,f   Foweraker, Juliet E ^b   Belcher, Carolyn E ^a   Moloo, Badru ^c   Bell, Judith A ^d   Humar, Atul ^e   Mazzulli, Tony ^e   Grant, David ^e  

^a Imutran Ltd   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f NONE   (United Kingdom)

Author keywords

Contamination; Microbiological safety; Xenograft harvest; Xenotransplantation

Indexed keywords

AMPICILLIN; CEFALOTIN; CEFAZOLIN; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NITROFURANTOIN; OFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; KIDNEY GRAFT; MICROBIAL CONTAMINATION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; BACTERIA; COLONY COUNT, MICROBIAL; HUMANS; INFECTION CONTROL; KIDNEY; KIDNEY TRANSPLANTATION; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; MONITORING, INTRAOPERATIVE; OPERATING ROOMS; SWINE; TISSUE AND ORGAN HARVESTING; TRANSPLANTATION, HETEROLOGOUS;

EID: 0742271153     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2004.00090.x     Document Type: Article

References (15)

1. COZZI E, WHITE D. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
2. COOPER DKC, YE Y, ROLF LL, ZUHDI N. The pig as a potential organ donor for man. In: COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG, eds. Xenotransplantation. Heidelberg: Springer-Verlag, 1995: 481.
3. SACHS DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994; 43: 185.
4. ONIONS D, COOPER DKC, ALEXANDER TJL et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 2000; 7: 143.
5. FISHMAN JA. Miniature swine as organ donors for man: strategies to prevent xenotransplant-associated infections. Xenotransplantation 1994; 1: 47.
6. US Public Health Service guideline on infectious disease issues in xenotransplantation. Fed Reg. 2001; 66: 8120.
7. TUCKER AW, BELCHER CE, MOLOO B et al. The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation 2002; 9: 191.
8. ASSELMEIER MA, CASPARI RB, BOTTENFIELD S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med 1993; 21: 170.
9. KEATING MR, GUERRERO MA, DALY RC et al. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 1996; 109: 1119.
10. TRICK WE, SCHECKLER WE, TOKARS JI et al. Risk factors for radial artery harvest site infection following coronary artery bypass graft surgery. Clin Infect Dis 2000 Feb; 30: 270.
11. BJOERSDORFF A, KORSGREN O, ANDERSSON J et al. Microbiologic screening as a preparatory step for clinical xenografting of porcine fetal islet-like cell clusters. Transplant Proc 1992; 24: 674.
12. GOUIN E, RIVEREAU A, DARQUY S et al. Minimisation of microbial contamination for potential islet xenografts using specific pathogen free pigs and a protected environment during tissue preparation. Diabet Metabol (Paris) 1997; 23: 537.
13. EVERETT E, HIRSCHMANN J. Transient bacteremia and endocarditis prophylaxis. A Rev Med 1977; 56: 61.
14. VAN GOOR H, ROSMAN C, GROND J et al. Translocation of bacteria and endotoxin in organ donors. Arch Surg 1994; 129: 1063.
15. McLAUCHLAN J, PILCHER M, TREXLER P et al. The surgical isolator. Br Med J 1974; 1: 322.